The global AI for Drug Discovery and Development market size was valued at USD 1155.5 million in 2023 and is forecast to a readjusted size of USD 3555.5 million by 2030 with a CAGR of 17.4% during review period.
Artificial intelligence has significant applications in the drug discovery field as it helps track diseases, create disease cures and predict which animal viruses appear to mutate. Artificial intelligence has been known to enhance R&D in drug discovery, which has helped researchers to discover chronic disease treatments. Drug discovery and development in the fields of medicine, pharmacology, and biotechnology are processes for the creation, design, and procurement of a drug through identifying a biological target, such as enzyme protein, gene, or receptor. Previously, the drugs were discovered by identifying the active ingredient conventional treatments. Thus, drug discovery is the first step in the process of identifying potential novel drugs and their medicinal purpose. New criteria for drugs are measured based on their bioavailability, efficacy, potency, and toxicity.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report includes an overview of the development of the AI for Drug Discovery and Development industry chain, the market status of Oncology (Target Identification, Molecule Screening), Infectious Disease (Target Identification, Molecule Screening), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of AI for Drug Discovery and Development.
Regionally, the report analyzes the AI for Drug Discovery and Development markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global AI for Drug Discovery and Development market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the AI for Drug Discovery and Development market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the AI for Drug Discovery and Development industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Target Identification, Molecule Screening).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the AI for Drug Discovery and Development market.
Regional Analysis: The report involves examining the AI for Drug Discovery and Development market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the AI for Drug Discovery and Development market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to AI for Drug Discovery and Development:
Company Analysis: Report covers individual AI for Drug Discovery and Development players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards AI for Drug Discovery and Development This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oncology, Infectious Disease).
Technology Analysis: Report covers specific technologies relevant to AI for Drug Discovery and Development. It assesses the current state, advancements, and potential future developments in AI for Drug Discovery and Development areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the AI for Drug Discovery and Development market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
AI for Drug Discovery and Development market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Target Identification
Molecule Screening
De Novo Drug Design and Drug Optimization
Preclinical and Clinical Testing
Others
Market segment by Application
Oncology
Infectious Disease
Neurology
Others
Market segment by players, this report covers
Alphabet
Atomwise
BenevolentAI
Cloud Pharmaceutical
Deep Genomics
Exscientia
IBM
Insilico Medicine
Microsoft Corporation
Nvidia Corporation
XtalPi
DP Technology
Tencent iDrug
PaddleHelix
EIHealth
Aliyun
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe AI for Drug Discovery and Development product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI for Drug Discovery and Development, with revenue, gross margin and global market share of AI for Drug Discovery and Development from 2019 to 2024.
Chapter 3, the AI for Drug Discovery and Development competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and AI for Drug Discovery and Development market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AI for Drug Discovery and Development.
Chapter 13, to describe AI for Drug Discovery and Development research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of AI for Drug Discovery and Development
1.2 Market Estimation Caveats and Base Year
1.3 Classification of AI for Drug Discovery and Development by Type
1.3.1 Overview: Global AI for Drug Discovery and Development Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global AI for Drug Discovery and Development Consumption Value Market Share by Type in 2023
1.3.3 Target Identification
1.3.4 Molecule Screening
1.3.5 De Novo Drug Design and Drug Optimization
1.3.6 Preclinical and Clinical Testing
1.3.7 Others
1.4 Global AI for Drug Discovery and Development Market by Application
1.4.1 Overview: Global AI for Drug Discovery and Development Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Oncology
1.4.3 Infectious Disease
1.4.4 Neurology
1.4.5 Others
1.5 Global AI for Drug Discovery and Development Market Size & Forecast
1.6 Global AI for Drug Discovery and Development Market Size and Forecast by Region
1.6.1 Global AI for Drug Discovery and Development Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global AI for Drug Discovery and Development Market Size by Region, (2019-2030)
1.6.3 North America AI for Drug Discovery and Development Market Size and Prospect (2019-2030)
1.6.4 Europe AI for Drug Discovery and Development Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific AI for Drug Discovery and Development Market Size and Prospect (2019-2030)
1.6.6 South America AI for Drug Discovery and Development Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa AI for Drug Discovery and Development Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Alphabet
2.1.1 Alphabet Details
2.1.2 Alphabet Major Business
2.1.3 Alphabet AI for Drug Discovery and Development Product and Solutions
2.1.4 Alphabet AI for Drug Discovery and Development Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Alphabet Recent Developments and Future Plans
2.2 Atomwise
2.2.1 Atomwise Details
2.2.2 Atomwise Major Business
2.2.3 Atomwise AI for Drug Discovery and Development Product and Solutions
2.2.4 Atomwise AI for Drug Discovery and Development Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Atomwise Recent Developments and Future Plans
2.3 BenevolentAI
2.3.1 BenevolentAI Details
2.3.2 BenevolentAI Major Business
2.3.3 BenevolentAI AI for Drug Discovery and Development Product and Solutions
2.3.4 BenevolentAI AI for Drug Discovery and Development Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 BenevolentAI Recent Developments and Future Plans
2.4 Cloud Pharmaceutical
2.4.1 Cloud Pharmaceutical Details
2.4.2 Cloud Pharmaceutical Major Business
2.4.3 Cloud Pharmaceutical AI for Drug Discovery and Development Product and Solutions
2.4.4 Cloud Pharmaceutical AI for Drug Discovery and Development Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Cloud Pharmaceutical Recent Developments and Future Plans
2.5 Deep Genomics
2.5.1 Deep Genomics Details
2.5.2 Deep Genomics Major Business
2.5.3 Deep Genomics AI for Drug Discovery and Development Product and Solutions
2.5.4 Deep Genomics AI for Drug Discovery and Development Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Deep Genomics Recent Developments and Future Plans
2.6 Exscientia
2.6.1 Exscientia Details
2.6.2 Exscientia Major Business
2.6.3 Exscientia AI for Drug Discovery and Development Product and Solutions
2.6.4 Exscientia AI for Drug Discovery and Development Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Exscientia Recent Developments and Future Plans
2.7 IBM
2.7.1 IBM Details
2.7.2 IBM Major Business
2.7.3 IBM AI for Drug Discovery and Development Product and Solutions
2.7.4 IBM AI for Drug Discovery and Development Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 IBM Recent Developments and Future Plans
2.8 Insilico Medicine
2.8.1 Insilico Medicine Details
2.8.2 Insilico Medicine Major Business
2.8.3 Insilico Medicine AI for Drug Discovery and Development Product and Solutions
2.8.4 Insilico Medicine AI for Drug Discovery and Development Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Insilico Medicine Recent Developments and Future Plans
2.9 Microsoft Corporation
2.9.1 Microsoft Corporation Details
2.9.2 Microsoft Corporation Major Business
2.9.3 Microsoft Corporation AI for Drug Discovery and Development Product and Solutions
2.9.4 Microsoft Corporation AI for Drug Discovery and Development Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Microsoft Corporation Recent Developments and Future Plans
2.10 Nvidia Corporation
2.10.1 Nvidia Corporation Details
2.10.2 Nvidia Corporation Major Business
2.10.3 Nvidia Corporation AI for Drug Discovery and Development Product and Solutions
2.10.4 Nvidia Corporation AI for Drug Discovery and Development Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Nvidia Corporation Recent Developments and Future Plans
2.11 XtalPi
2.11.1 XtalPi Details
2.11.2 XtalPi Major Business
2.11.3 XtalPi AI for Drug Discovery and Development Product and Solutions
2.11.4 XtalPi AI for Drug Discovery and Development Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 XtalPi Recent Developments and Future Plans
2.12 DP Technology
2.12.1 DP Technology Details
2.12.2 DP Technology Major Business
2.12.3 DP Technology AI for Drug Discovery and Development Product and Solutions
2.12.4 DP Technology AI for Drug Discovery and Development Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 DP Technology Recent Developments and Future Plans
2.13 Tencent iDrug
2.13.1 Tencent iDrug Details
2.13.2 Tencent iDrug Major Business
2.13.3 Tencent iDrug AI for Drug Discovery and Development Product and Solutions
2.13.4 Tencent iDrug AI for Drug Discovery and Development Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Tencent iDrug Recent Developments and Future Plans
2.14 PaddleHelix
2.14.1 PaddleHelix Details
2.14.2 PaddleHelix Major Business
2.14.3 PaddleHelix AI for Drug Discovery and Development Product and Solutions
2.14.4 PaddleHelix AI for Drug Discovery and Development Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 PaddleHelix Recent Developments and Future Plans
2.15 EIHealth
2.15.1 EIHealth Details
2.15.2 EIHealth Major Business
2.15.3 EIHealth AI for Drug Discovery and Development Product and Solutions
2.15.4 EIHealth AI for Drug Discovery and Development Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 EIHealth Recent Developments and Future Plans
2.16 Aliyun
2.16.1 Aliyun Details
2.16.2 Aliyun Major Business
2.16.3 Aliyun AI for Drug Discovery and Development Product and Solutions
2.16.4 Aliyun AI for Drug Discovery and Development Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Aliyun Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global AI for Drug Discovery and Development Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of AI for Drug Discovery and Development by Company Revenue
3.2.2 Top 3 AI for Drug Discovery and Development Players Market Share in 2023
3.2.3 Top 6 AI for Drug Discovery and Development Players Market Share in 2023
3.3 AI for Drug Discovery and Development Market: Overall Company Footprint Analysis
3.3.1 AI for Drug Discovery and Development Market: Region Footprint
3.3.2 AI for Drug Discovery and Development Market: Company Product Type Footprint
3.3.3 AI for Drug Discovery and Development Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global AI for Drug Discovery and Development Consumption Value and Market Share by Type (2019-2024)
4.2 Global AI for Drug Discovery and Development Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global AI for Drug Discovery and Development Consumption Value Market Share by Application (2019-2024)
5.2 Global AI for Drug Discovery and Development Market Forecast by Application (2025-2030)
6 North America
6.1 North America AI for Drug Discovery and Development Consumption Value by Type (2019-2030)
6.2 North America AI for Drug Discovery and Development Consumption Value by Application (2019-2030)
6.3 North America AI for Drug Discovery and Development Market Size by Country
6.3.1 North America AI for Drug Discovery and Development Consumption Value by Country (2019-2030)
6.3.2 United States AI for Drug Discovery and Development Market Size and Forecast (2019-2030)
6.3.3 Canada AI for Drug Discovery and Development Market Size and Forecast (2019-2030)
6.3.4 Mexico AI for Drug Discovery and Development Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe AI for Drug Discovery and Development Consumption Value by Type (2019-2030)
7.2 Europe AI for Drug Discovery and Development Consumption Value by Application (2019-2030)
7.3 Europe AI for Drug Discovery and Development Market Size by Country
7.3.1 Europe AI for Drug Discovery and Development Consumption Value by Country (2019-2030)
7.3.2 Germany AI for Drug Discovery and Development Market Size and Forecast (2019-2030)
7.3.3 France AI for Drug Discovery and Development Market Size and Forecast (2019-2030)
7.3.4 United Kingdom AI for Drug Discovery and Development Market Size and Forecast (2019-2030)
7.3.5 Russia AI for Drug Discovery and Development Market Size and Forecast (2019-2030)
7.3.6 Italy AI for Drug Discovery and Development Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific AI for Drug Discovery and Development Consumption Value by Type (2019-2030)
8.2 Asia-Pacific AI for Drug Discovery and Development Consumption Value by Application (2019-2030)
8.3 Asia-Pacific AI for Drug Discovery and Development Market Size by Region
8.3.1 Asia-Pacific AI for Drug Discovery and Development Consumption Value by Region (2019-2030)
8.3.2 China AI for Drug Discovery and Development Market Size and Forecast (2019-2030)
8.3.3 Japan AI for Drug Discovery and Development Market Size and Forecast (2019-2030)
8.3.4 South Korea AI for Drug Discovery and Development Market Size and Forecast (2019-2030)
8.3.5 India AI for Drug Discovery and Development Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia AI for Drug Discovery and Development Market Size and Forecast (2019-2030)
8.3.7 Australia AI for Drug Discovery and Development Market Size and Forecast (2019-2030)
9 South America
9.1 South America AI for Drug Discovery and Development Consumption Value by Type (2019-2030)
9.2 South America AI for Drug Discovery and Development Consumption Value by Application (2019-2030)
9.3 South America AI for Drug Discovery and Development Market Size by Country
9.3.1 South America AI for Drug Discovery and Development Consumption Value by Country (2019-2030)
9.3.2 Brazil AI for Drug Discovery and Development Market Size and Forecast (2019-2030)
9.3.3 Argentina AI for Drug Discovery and Development Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa AI for Drug Discovery and Development Consumption Value by Type (2019-2030)
10.2 Middle East & Africa AI for Drug Discovery and Development Consumption Value by Application (2019-2030)
10.3 Middle East & Africa AI for Drug Discovery and Development Market Size by Country
10.3.1 Middle East & Africa AI for Drug Discovery and Development Consumption Value by Country (2019-2030)
10.3.2 Turkey AI for Drug Discovery and Development Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia AI for Drug Discovery and Development Market Size and Forecast (2019-2030)
10.3.4 UAE AI for Drug Discovery and Development Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 AI for Drug Discovery and Development Market Drivers
11.2 AI for Drug Discovery and Development Market Restraints
11.3 AI for Drug Discovery and Development Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 AI for Drug Discovery and Development Industry Chain
12.2 AI for Drug Discovery and Development Upstream Analysis
12.3 AI for Drug Discovery and Development Midstream Analysis
12.4 AI for Drug Discovery and Development Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Alphabet
Atomwise
BenevolentAI
Cloud Pharmaceutical
Deep Genomics
Exscientia
IBM
Insilico Medicine
Microsoft Corporation
Nvidia Corporation
XtalPi
DP Technology
Tencent iDrug
PaddleHelix
EIHealth
Aliyun
听
听
*If Applicable.